Evidence map›Paper›PMID 30867312›Full record

ArticleJournal of virology2019

Human Cytomegalovirus DNA Polymerase Subunit UL44 Antagonizes Antiviral Immune Responses by Suppressing IRF3- and NF-κB-Mediated Transcription.

Yu-Zhi Fu, Shan Su, Hong-Mei Zou, Yi Guo, Su-Yun Wang, Shu Li, Min-Hua Luo, Yan-Yi Wang

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Human cytomegalovirus and neonatal infection.Current research in microbial sciences · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Deletion of the non-adjacent genesFrontiers in immunology · 2023
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yu-Zhi FuKey Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
Shan SuMedical Research Institute, School of Medicine, Wuhan University, Wuhan, China.
Hong-Mei ZouKey Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
Yi GuoMedical Research Institute, School of Medicine, Wuhan University, Wuhan, China.
Su-Yun WangKey Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
Shu LiMedical Research Institute, School of Medicine, Wuhan University, Wuhan, China.
Min-Hua LuoKey Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.ORCID 0000-0001-9352-0643
Yan-Yi WangKey Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China wangyy@wh.iov.cn.
Chinese Academy of Sciences · CNWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Innate immunity is the first line of host defense against viral invasion. The induction of type I interferons (IFNs) and inflammatory cytokines is essential to host antiviral immune responses, which are also key targets of viral immune evasion. Human cytomegalovirus (HCMV) can establish long-term latent infections, in which immune evasion is a pivotal step. In this study, we identified HCMV protein UL44, a DNA polymerase processivity factor, as an inhibitor of the interferon regulatory factor 3 (IRF3)- and NF-κB-dependent antiviral response. Ectopic expression of UL44 inhibited HCMV-triggered induction of downstream effector genes and enhanced viral replication. Conversely, knockdown of UL44 potentiated HCMV-triggered induction of downstream antiviral genes. UL44 interacted with IRF3 and p65, and it inhibited the binding of IRF3 and NF-κB to the promoters of their downstream antiviral genes. These findings reveal an important mechanism of immune evasion by HCMV at the transcriptional level.

Indexed as

Antiviral AgentsCytomegalovirusDNA-Binding ProteinsDNA-Directed DNA PolymeraseHEK293 CellsHost-Pathogen InteractionsHumansImmune EvasionImmunity, InnateInterferon Regulatory Factor-3Interferon Type INF-kappa BSignal TransductionViral ProteinsVirus ReplicationAntiviral AgentsDNA-Binding ProteinsDNA-Directed DNA PolymeraseICP36 protein, CytomegalovirusInterferon Regulatory Factor-3Interferon Type IIRF3 protein, humanNF-kappa BViral ProteinsHCMVimmune evasioninnate immunityIRF3NF-κBtype I interferonsUL44

Identifiers

PMID30867312
PMCPMC6532097
OpenAlexW2921486374

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.